Autoimmune Disease Diagnostics Market to Exceed USD 12 Billion by 2031 as AI and CRISPR Transform Detection

0
229

[Boston, MA, April 21st, 2025] – The Global Autoimmune Disease Diagnosis Market, valued at USD 5.6 billion in 2023, is expected to grow at a CAGR of 10.5%, reaching USD 12.4 billion by 2031, driven by AI pattern recognition and CRISPR-based detection systems, according to ClearView Market Insights.

Request Sample @ https://clearviewmarketinsights.com/report-details/global-autoimmune-disease-diagnosis-market/

2024 Diagnostic Revolution

  • AI systems now predict disease flares 6 months in advance
  • CRISPR diagnostics deliver results in under 30 minutes
  • Point-of-care testing reaches lab-quality accuracy

Clinical Adoption Surge

  • 85% of specialists now use advanced diagnostic tools
  • Post-COVID autoimmunity driving 27% more cases

Technology Leaders

  • North America (40%): AI and CRISPR adoption leader
  • Europe (XX%): Gold-standard diagnostic guidelines
  • Asia (XX%): Rapid healthcare infrastructure growth

Expert Commentary

"We're entering an era where autoimmune diseases can be detected years before symptoms appear."
— Dr. Elena Rodriguez, Harvard Autoimmunity Institute

Market Evolution

  • 2025: 50% of lupus cases diagnosed via AI
  • 2027: CRISPR home tests enter consumer market
  • 2030: Pre-symptomatic detection becomes standard of care

 

For more insights, visit https://clearviewmarketinsights.com/report-store  

About ClearView Market Insights

Specialists in medical diagnostics and precision medicine markets.

 

 

Media contact:

Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: 
sales@clearviewmarketinsights.com
Phone: +1 917-993-7369

 

 

Sponsor
Sponsor
Sponsor
Babafig https://www.babafig.com